Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Cancer Res. 2017 May 23;77(15):3990–3999. doi: 10.1158/0008-5472.CAN-16-2393

Figure 3. Expression of IDH2K413Q promotes a transformation permissive phenotype.

Figure 3

(a) Fifty MCF7-shIDH2-IDH2WT, MCF7-shIDH2-IDH2K413R, or MCF7-shIDH2-IDH2K413Q cells were plated on a 6-well cell culture plate for 14 days before colonies were stained using crystal violet. (b) Quantification of colony numbers (n=4). (c) Two hundred and fifty MCF7-shSIRT3-PCDH, MCF7-shSIRT3-IDH2K413R and MCF7-shSIRT3-IDH2K413Q cells were plated on a 6-well cell culture plate for 14 days before colonies were stained using crystal violet. (d) Quantification of colony numbers (n=4). (e) Tumors from immunodeficient mice injected with five million MCF7-shIDH2-IDH2WT, MCF7-shIDH2-IDH2K413R, or MCF7-shIDH2-IDH2K413Q cells were harvested and weighed (n=5). (f) Tumor growth was measured starting at day six of tumor incidence (n=5). Results are the average of five biological replicates, and error bars represent one standard deviation. * indicates p<0.05, ** indicates p<0.01, comparing to WT by two-tailed unpaired t-test using Prism 6.0.